Tag: ANDA
FDA nod for Alembic Pharma’s generic acne cream
Vadodara-headquartered Alembic Pharmaceuticals (Alembic) has announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New...
USFDA approves for marketing of Pirfenidone tablets
Alembic Pharmaceuticals stated that the regulator of the US health had allowed the marketing of Pirfenidone tablets used for the treatment of lung disease...
Alembic Pharmaceuticals buys 100% stake in Aleor Dermaceuticals
On 5 April, Vadodara-based Alembic Pharmaceuticals said that it has possessed a 100% stake in Aleor Dermaceuticals. The objective is to strengthen the skin-related...
Glenmark Pharmaceuticals receives ANDA tentative approval for Axitinib tablets
Glenmark Pharmaceuticals USA (Glenmark) has received tentative approval by the United States Food and Drug Administration (US FDA) for Axitinib Tablets, 1 mg and...
Zydus receives tentative approval from USFDA for Empagliflozin and Metformin Hydrochloride...
Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin and
Metformin Hydrochloride Tablets, 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg,...
Strides receives USFDA approval for Tetracycline Hydrochloride capsules
Strides Pharma Science has announced that its step-down wholly-owned subsidiary, Strides Pharma Global, Singapore, has received approval for Tetracycline Hydrochloride capsules USP, 250 mg,...




